Xenotransplantation - Current status and future perspectives

British Medical Bulletin

Volumn 75-76, Issue 1, 2005, Pages 99-114

  Cozzi, Emanuele ^a,b,c   Bosio, Erika ^b,c   Seveso, Michela ^b   Vadori, Marta ^b,c   Ancona, Ermanno ^a,b,c  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b CORIT ^*  (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Coagulation; Genetic engineering; Humoral rejection; Pig; Primate; Safety; Xenotransplantation

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; COBROTOXIN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C5 ANTIBODY; CYCLOSPORIN; EVEROLIMUS; FIBRINOGEN RECEPTOR ANTAGONIST; FINGOLIMOD; HEPARAN SULFATE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY; LEFLUNOMIDE; PROTEIN ANTIBODY; PROTEIN INHIBITOR; UNCLASSIFIED DRUG;

BIOLOGICAL MODEL; BLOOD CLOTTING DISORDER; CHRONIC GRAFT REJECTION; GENETIC ENGINEERING; GRAFT SURVIVAL; HUMORAL IMMUNITY; HYPERACUTE GRAFT REJECTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL RESEARCH; NONHUMAN; ORGAN DONOR; ORGAN TRANSPLANTATION; PANCREAS ISLET CELL; PRIMATE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SAFETY; SURVIVAL TIME; SWINE; XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; BLOOD COAGULATION; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 33747613376     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldh061     Document Type: Review

References (79)

1. Deschamps JY, Roux FA, Sai P et al. History of xenotransplantation. Xenotransplantation 2005;12:91-109.
2. Srinivasan A, Burton EC, Kuehnert MJ et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005;352:1103-11.
3. Buell JF, Beebe TM, Trofe J et al. Donor transmitted malignancies. Ann Transplant 2004;9:53-6.
4. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995;1:964-6.
5. Pino-Chavez G. Differentiating acute humoral from acute cellular rejection histopathologically. Graft 2001;4:60-3.
6. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991;52:937-47.
7. Yin D, Zeng H, Ma L et al. Cutting edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol 2004;172:7235-8.
8. Cozzi E, Seveso M, Bosio E et al. Antibody mediated rejection in pig-to-nonhuman primate xenotransplantation models. Curr Drug Targets Cardiovasc Haematol Disord 2005;5:233-53.
9. Lai L, Kolber-Simonds D, Park KW et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002;295:1089-92.
10. Kuwaki K, Tseng YL, Dor FJ et al. Heart transplantation in baboons using alpha1,3-galactosyltransferase gene-knockout pigs as donors: initial experience. Nat Med 2005;11:29-31.
11. Yamada K, Yazawa K, Shimizu A et al. Marked prolongation of porcine renal xenograft survival in baboons through the use of alpha1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue. Nat Med 2005;11:32-4.
12. Sharma A, Naziruddin B, Cui C et al. Pig cells that lack the gene for alpha1-3 galactosyltransferase express low levels of the gal antigen. Transplantation 2003;75:430-6.
13. Mollnes TE, Fiane AE. Perspectives on complement in xenotransplantation. Mol Immunol 2003;40:135-43.
14. Schuurman HJ, Pino-Chavez G, Phillips MJ et al. Incidence of hyperacute rejection in pig-toprimate transplantation using organs from hDAF-transgenic donors. Transplantation 2002;73:1146-51.
15. McCurry KR, Kooyman DL, Alvarado CG et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1995;1:423-7.
16. Chen RH, Naficy S, Logan JS et al. Hearts from transgenic pigs constructed with CD59/DAF genomic clones demonstrate improved survival in primates. Xenotransplantation 1999;6:194-200.
17. Bach FH, Robson SC, Ferran C et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994;141:5-30.
18. Cozzi E, Bhatti F, Schmoeckel M et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000;70:15-21.
19. Zhong R, Luo Y, Yang H et al. Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL. Transplantation 2003;75:10-9.
20. Lin SS, Weidner BC, Byrne GW et al. The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants. J Clin Invest 1998;101:1745-56.
21. Chen G, Qian H, Starzl T et al. Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med 2005;11:1295-8.
22. Buhler LH, Cooper DK. How strong is the T cell response in the pig-to-primate model? Xenotransplantation 2005;12:85-7.
23. Sebille F, Guillet M, Brouard S et al. T-cell-mediated rejection of vascularized xenografts in the absence of induced anti-donor antibody response. Am J Transplant 2001;1:21-8.
24. Shen J, Chong AS, Xiao F et al. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Transplantation 1998;66:692-8.
25. Simeonovic CJ. Xenogeneic islet transplantation. Xenotransplantation 1999;6:1-5.
26. Dor FJ, Cheng J, Alt A et al. Galalpha1,3Gal expression on porcine pancreatic islets, testis, spleen, and thymus. Xenotransplantation 2004;11:101-6.
27. Brissova M, Fowler M, Wiebe P et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 2004;53:1318-25.
28. Bennet W, Sundberg B, Lundgren T et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000;69:711-9.
29. Goto M, Johansson H, Maeda A et al. Low molecular weight dextran sulfate prevents the instant blood-mediated inflammatory reaction induced by adult porcine islets. Transplantation 2004;77:741-7.
30. Soderlund J, Wennberg L, Castanos-Velez E et al. Fetal porcine islet-like cell clusters transplanted to cynomolgus monkeys: an immunohistochemical study. Transplantation 1999;67:784-91.
31. Kirchhof N, Shibata S, Wijkstrom M et al. Reversal of diabetes in non-immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection. Xenotransplantation 2004;11:396-407.
32. Hering BJ, Wijkstrom M, Graham ML et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006;12:301-3.
33. Buhler L, Deng S, O'Neil J et al. Adult porcine islet transplantation in baboons treated with conventional immunosuppression or a non-myeloablative regimen and CD154 blockade. Xenotransplantation 2002;9:3-13.
34. Rijkelijkhuizen JK, Haanstra KG, Wubben J et al. T-cell-specific immunosuppression results in more than 53 days survival of porcine islets of Langerhans in the monkey. Transplantation 2003;76:1359-68.
35. Sun Y, Ma X, Zhou D et al. Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 1996;98:1417-22.
36. Klose R, Kemter E, Bedke T et al. Expression of biologically active human TRAIL in transgenic pigs. Transplantation 2005;80:222-30.
37. Koch CA, Khalpey ZI, Platt JL. Accommodation: preventing injury in transplantation and disease. J Immunol 2004;172:5143-8.
38. Shibata T, Cosio FG, Birmingham DJ. Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol 1991;147:3901-8.
39. Dalmasso AP, Benson BA, Johnson JS et al. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression. J Immunol 2000;164:3764-73.
40. Bach FH, Hancock WW, Ferran C. Protective genes expressed in endothelial cells: a regulatory response to injury. Immunol Today 1997;18:483-6.
41. Williams JM, Holzknecht ZE, Plummer TB et al. Acute vascular rejection and accommodation: divergent outcomes of the humoral response to organ transplantation. Transplantation 2004;78:1471-8.
42. Tseng YL, Dor FJ, Kuwaki K et al. Bone marrow transplantation from alpha1,3-galactosyltransferase gene-knockout pigs in baboons. Xenotransplantation 2004;11:361-70.
43. Cosimi AB, Sachs DH. Mixed chimerism and transplantation tolerance. Transplantation 2004;77:943-6.
44. Wood KJ. Is B cell tolerance essential for transplantation tolerance? Transplantation 2005;79:S40-2.
45. Sykes M, Shimizu I, Kawahara T. Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance. Transplantation 2005;79:S28-9.
46. Kanmaz T, Fechner JJ Jr, Torrealba J et al. Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. Transplantation 2004;77:914-20.
47. Schuler W, Bigaud M, Brinkmann V et al. Efficacy and safety of ABI793, a novel human antihuman CD154 monoclonal antibody, in cynomolgus monkey renal allotransplantation. Transplantation 2004;77:717-26.
48. Cooper DK, Gollackner B, Sachs DH. Will the pig solve the transplantation backlog? Annu Rev Med 2002;53:133-47.
49. Byrne G, Davila E, Davies W et al. Orthotopic pig to primate cardiac xenotransplantation. Xenotransplantation 2005;12:379.
50. Vial CM, Ostlie DJ, Bhatti FN et al. Life supporting function for over one month of a transgenic porcine heart in a baboon. J Heart Lung Transplant 2000;19:224-9.
51. Baldan N, Rigotti P, Calabrese F et al. Ureteral stenosis in HDAF pig-to-primate renal xenotransplantation: a phenomenon related to immunological events? Am J Transplant 2004;4:475-81.
52. Robson SC, Cooper DK, d'Apice AJ. Disordered regulation of coagulation and platelet activation in xenotransplantation. Xenotransplantation 2000;7:166-76.
53. Soin B, Smith KG, Zaidi A et al. Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int 2001;60:1592-7.
54. Osborne FN, Kalsi KK, Lawson C et al. Expression of human ecto-5′-nucleotidase in pig endothelium increases adenosine production and protects from NK cell-mediated lysis. Am J Transplant 2005;5:1248-55.
55. Chen D, Riesbeck K, McVey JH et al. Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins. Transplantation 1999;68:832-9.
56. Dwyer KM, Robson SC, Nandurkar HH et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004;113:1440-6.
57. Chen D, Weber M, McVey JH et al. Complete inhibition of acute humoral rejection using regulated expression of membrane-tethered anticoagulants on xenograft endothelium. Am J Transplant 2004;4:1958-63.
58. Toomey JR, Kratzer KE, Lasky NM et al. Effect of tissue factor deficiency on mouse and tumor development. Proc Natl Acad Sci USA 1997;94:6922-6.
59. Weiss EJ, Hamilton JR, Lease KE et al. Protection against thrombosis in mice lacking PAR3. Blood 2002;100:3240-4.
60. Mendicino M, Liu M, Ghanekar A et al. Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts. Circulation 2005;112:248-56.
61. McGregor CG, Davies WR, Oi K et al. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival. J Thorac Cardiovasc Surg 2005;130:844-51.
62. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 2004;4:1383-90.
63. Takeuchi Y, Patience C, Magre S et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998;72:9986-91.
64. Oldmixon BA, Wood JC, Ericsson TA et al. Porcine endogenous retrovirus transmission characteristics of an inbred herd of miniature swine. J Virol 2002;76:3045-8.
65. Bartosch B, Stefanidis D, Myers R et al. Evidence and consequence of porcine endogenous retrovirus recombination. J Virol 2004;78:13880-90.
66. Scobie L, Taylor S, Logan NA et al. Characterization of germline porcine endogenous retroviruses from large white pig. J Gen Virol 2004;85:2421-8.
67. Mueller NJ, Livingston C, Knosalla C et al. Activation of porcine cytomegalovirus, but not porcine lymphotropic herpesvirus, in pig-to-baboon xenotransplantation. J Infect Dis 2004;189:1628-33.
68. Mueller NJ, Kuwaki K, Dor FJ et al. Reduction of consumptive coagulopathy using porcine cytomegalovirus-free cardiac porcine grafts in pig-to-primate xenotransplantation. Transplantation 2004;78:1449-53.
69. Quinn G, Wood JC, Ryan DJ et al. Porcine endogenous retrovirus transmission characteristics of galactose alpha1-3 galactose-deficient pig cells. J Virol 2004;78:5805-11.
70. Magre S, Takeuchi Y, Langford G et al. Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope. J Virol 2004;78:5812-9.
71. Weiss RA. Transgenic pigs and virus adaptation. Nature 1998;391:327-8.
72. Wilhelm M, Fishman JA, Pontikis R et al. Susceptibility of recombinant porcine endogenous retrovirus reverse transcriptase to nucleoside and non-nucleoside inhibitors. Cell Mol Life Sci 2002;59:2184-90.
73. Scobie L, Taylor S, Wood JC et al. Absence of replication-competent human-tropic porcine endogenous retroviruses in the germ line DNA of inbred miniature Swine. J Virol 2004;78:2502-9.
74. Fiebig U, Stephan O, Kurth R et al. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology 2003;307:406-13.
75. Miyagawa S, Nakatsu S, Nakagawa T et al. Prevention of PERV infections in pig to human xenotransplantation by the RNA interference silences gene. J Biochem (Tokyo) 2005;137:503-8.
76. Wang D, Coscoy L, Zylberberg M et al. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci USA 2002;99:15687-92.
77. Sykes M, d'Apice A, Sandrin M. Position paper of the Ethics Committee of the International Xenotransplantation Association. Xenotransplantation 2003;10:194-203.
78. From the Eighth Plenary Meeting of the Fifty-Seventh World Health Assembly in Geneva. Human organ and tissue transplantation. Transplantation 2005;79:635.
79. Valdes-Gonzalez RA, Dorantes LM, Garibay GN et al. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur J Endocrinol 2005;153:419-27.